Literature DB >> 3456179

Isolation of cowpox virus A-type inclusions and characterization of their major protein component.

D D Patel, D J Pickup, W K Joklik.   

Abstract

A-type inclusions (ATI)2 are large well-defined structures that appear in the cytoplasm during the late stages of the multiplication cycles of many poxviruses. The ATIs produced by the CPRC1 strain of cowpox virus in strain 143 human osteosarcoma cells have been isolated and characterized. These inclusions which can be recovered in large amounts (about 20 mg per 10(9) cells), appear to consist entirely of a single protein species that has a molecular weight of 160,000. It is a late protein, stable in infected cells, and during the late stages of the multiplication cycle it is one of the most abundantly synthesized proteins. Very similar ATIs composed of a serologically closely related protein of the same size are formed in cells infected with raccoonpox virus. In cells infected with vaccinia virus strain WR much smaller inclusions are formed; further, in such cells large amounts of a late protein with a molecular weight of 94,000 are produced that is also closely related to the cowpox virus ATI protein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456179     DOI: 10.1016/0042-6822(86)90119-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  43 in total

1.  Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells.

Authors:  Shu-Jung Chang; Yu-Xun Chang; Roza Izmailyan; Yin-Liang Tang; Wen Chang
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

2.  Site-specific RNA cleavage generates the 3' end of a poxvirus late mRNA.

Authors:  J B Antczak; D D Patel; C A Ray; B S Ink; D J Pickup
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

3.  Type A intracytoplasmic inclusions in human cowpox infection.

Authors:  S D Lawn; S Holwill
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

4.  Failure of the smallpox vaccine to develop a skin lesion in vaccinia virus-naïve individuals is related to differences in antibody profiles before vaccination, not after.

Authors:  Xiaolin Tan; Sookhee Chun; Jozelyn Pablo; Philip Felgner; Xiaowu Liang; D Huw Davies
Journal:  Clin Vaccine Immunol       Date:  2012-01-18

5.  Out of the Reservoir: Phenotypic and Genotypic Characterization of a Novel Cowpox Virus Isolated from a Common Vole.

Authors:  Donata Hoffmann; Annika Franke; Maria Jenckel; Aistė Tamošiūnaitė; Julia Schluckebier; Harald Granzow; Bernd Hoffmann; Stefan Fischer; Rainer G Ulrich; Dirk Höper; Katja Goller; Nikolaus Osterrieder; Martin Beer
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

6.  Increased expression in vivo and in vitro of foreign genes directed by A-type inclusion body hybrid promoters in recombinant vaccinia viruses.

Authors:  S Funahashi; S Itamura; H Iinuma; K Nerome; M Sugimoto; H Shida
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  The vaccinia virus 4c and A-type inclusion proteins are specific markers for the intracellular mature virus particle.

Authors:  D Ulaeto; D Grosenbach; D E Hruby
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 8.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

9.  Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases.

Authors:  D J Pickup; B S Ink; W Hu; C A Ray; W K Joklik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

10.  Identification and characterization of three immunodominant structural proteins of fowlpox virus.

Authors:  Denise Boulanger; Philip Green; Brenda Jones; Gwenn Henriquet; Lawrence G Hunt; Stephen M Laidlaw; Paul Monaghan; Michael A Skinner
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.